Data gathered: January 27
AI Stock Analysis - Boston Scientific (BSX)
Analysis generated December 31, 2024. Powered by Chat GPT.
Boston Scientific Corporation (NYSE: BSX) is a global medical technology leader, developing and manufacturing a wide range of high-performance medical solutions used to improve the health of patients around the world. The company is dedicated to transforming lives through innovative medical solutions that improve the health of patients. Boston Scientific operates in three primary segments: Medical-Surgical (MedSurg), Rhythm and Neuro, and Cardiovascular.
Stock Alerts - Boston Scientific (BSX)
 |
Boston Scientific | January 11 Over the past few months, there has been an downward trend in Web Traffic. |
|
Boston Scientific | January 11 Employee Rating is up by 2.4% over the last month. |
|
Boston Scientific | January 10 AI Score is up by 21.8% in the last couple of days. |
|
Boston Scientific | January 8 News Alert: Boston Scientific to acquire Bolt Medical for upfront payment of $443M |
Alternative Data for Boston Scientific
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 902 | Sign up | Sign up | Sign up |
| Sentiment | 89 | Sign up | Sign up | Sign up |
| Webpage traffic | 563,000 | Sign up | Sign up | Sign up |
| Employee Rating | 84 | Sign up | Sign up | Sign up |
| Google Trends | 34 | Sign up | Sign up | Sign up |
| Patents | 3,852 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 291 | Sign up | Sign up | Sign up |
| Facebook Followers | 71,494 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 5,963 | Sign up | Sign up | Sign up |
| Twitter Followers | 40,687 | Sign up | Sign up | Sign up |
| Twitter Mentions | 129 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 44 | Sign up | Sign up | Sign up |
| ESG | 81 | Sign up | Sign up | Sign up |
| Lobbying Cost | $127,000 | Sign up | Sign up | Sign up |
| Business Outlook | 79 | Sign up | Sign up | Sign up |
| Linkedin Employees | 46,879 | Sign up | Sign up | Sign up |
| NPS | 21 | Sign up | Sign up | Sign up |
About Boston Scientific
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
| Price | $101.87 |
| Target Price | Sign up |
| Volume | 3,170,000 |
| Market Cap | $150B |
| Year Range | $72.96 - $101.94 |
| Dividend Yield | 0% |
| PE Ratio | 84.25 |
| Analyst Rating | 94% buy |
| Earnings Date | February 5 '25 |
| Industry | Medical Devices |
In the news
 |
Boston Scientific (BSX) to Release Earnings on WednesdayJanuary 26 - ETF Daily News |
|
Ameritas Advisory Services LLC Takes Position in Boston Scientific Co. (NYSE:BSX)January 23 - ETF Daily News |
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gainsJanuary 23 - MarketWatch |
|
Boston Scientific : 4 things to know about our acquisition of Axonics, Inc.January 21 - Finnhub |
|
Uterine Fibroids Treatment Devices Market Analysis and Shares Outlook 2025-2030, Featuring Medtronic, Stryker, Boston Scientific Corp, Insightec, CooperSurgical & MoreJanuary 21 - GlobeNewswire |
|
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gainsJanuary 21 - MarketWatch |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 4.13B | 3.09B | 2.9B | 468M | 952M | 0.630 |
| Q2 '24 | 4.04B | 3.22B | 2.85B | 324M | 712M | 0.620 |
| Q1 '24 | 3.79B | 2.8B | 2.65B | 492M | 890M | 0.560 |
| Q4 '23 | 3.66B | 2.76B | 2.58B | 503M | 777M | 0.550 |
| Q3 '23 | 3.46B | 2.58B | 2.43B | 504M | 883M | 0.500 |
Insider Transactions View All
| Brennan Daniel J. filed to sell 223,921 shares at $89.9. January 3 '25 |
| Mirviss Jeffrey B. filed to sell 28,454 shares at $89.9. January 3 '25 |
| Sorenson John Bradley filed to sell 32,977 shares at $89.9. January 3 '25 |
| Sorenson John Bradley filed to sell 35,319 shares at $90. January 3 '25 |
| Carruthers Wendy filed to sell 29,308 shares at $90.8. December 4 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Michael McCaul Republican |
May 17, 24 | Sell | $15K - $50K |
| Michael McCaul Republican |
May 17, 24 | Sell | $50K - $100K |
| Michael McCaul Republican |
May 17, 24 | Sell | $100K - $250K |
Read more about Boston Scientific (BSX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Boston Scientific?
The Market Cap of Boston Scientific is $150B.
What is Boston Scientific's PE Ratio?
As of today, Boston Scientific's PE (Price to Earnings) ratio is 84.25.
When does Boston Scientific report earnings?
Boston Scientific will report its next earnings on February 5 '25.
What is the current stock price of Boston Scientific?
Currently, the price of one share of Boston Scientific stock is $101.87.
How can I analyze the BSX stock price chart for investment decisions?
The BSX stock price chart above provides a comprehensive visual representation of Boston Scientific's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Boston Scientific shares. Our platform offers an up-to-date BSX stock price chart, along with technical data analysis and alternative data insights.
Does BSX offer dividends to its shareholders?
As of our latest update, Boston Scientific (BSX) does not offer dividends to its shareholders. Investors interested in Boston Scientific should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Boston Scientific?
Some of the similar stocks of Boston Scientific are Edwards Lifesciences, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
.